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LEDGF gene silencing impairs the tumorigenicity of
prostate cancer DU145 cells by abating the expression
of Hsp27 and activation of the Akt/ERK signaling
pathway
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Lensepithelium-derivedgrowthfactor(LEDGF)maintainssurvivalpathwaysbyaugmentingthetranscriptionofstress-response
genes such as small heat-shock protein 27. Recently, aberrant expression of LEDGF was found in prostate cancer (PC). Herein,
we showed that LEDGF overexpression upregulated Hsp27 in PC cells, DU145, PC-3 and LNCaP and promoted antiapoptotic
pathways in PCs. We found that these cells had higher abundance of Hsp27, which was correlated with the levels of LEDGF
expression. Transactivation assay in DU145 cells revealed that transactivation of Hsp27 was related to the magnitude of LEDGF
expression. Silencing of LEDGF in DU145 cells abrogated Hsp27 expression and inhibited stimulated cell proliferation,
invasiveness and migration. These cells were arrested in S and G2 phase, and failed to accumulate cyclin B1, and showed
increased apoptosis. Furthermore, LEDGF-depleted DU145 cells displayed elevated Bax and cleaved caspase 9 expression and
reduced levels of Bcl2, Bcl-XL. The activated survival pathway(s), ERK1/2 and Akt, were selectively decreased in these cells,
whichcharacteristicallyhavelowertumorigenicity.Conversely,thedepletedcells,whenre-overexpressedwithLEDGForHsp27,
regained tumorigenic properties. Collectively, results reveal the involvement of LEDGF-mediated elevated expression of Hsp27-
dependent survival pathway(s) in PC. Our ﬁndings suggest new lines of investigation aimed at developing therapies by targeting
LEDGF or its aberrant expression-associated stimulated antiapoptotic pathway(s).
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A multi-domain ﬂexible nuclear protein, lens epithelium-
derived growth factor (LEDGF), exercises a variety of
functions involving cellular abnormalities by interacting with
DNA/protein.
1–5 LEDGF was originally identiﬁed as a tran-
scriptional protein that binds to chromatin/DNA
1,6 mapped to
chromosome 9p22.3 genetic locus.
2,7 Recently, LEDGF has
been shown to interact with multiple proteins such as Myc-
interacting protein JPO2
8 and mixed-lineage leukemia/menin
complex,
9 a domesticated transposase pogo transposable
element-derived protein with zinc ﬁnger
10 and Cdc7-activator
of S-phase kinase (ASK).
11 Furthermore, its helix-turn-
helix-like motifs (aa, 421–442 and aa, 471–492) bind to
heat-shock element (nGAAn), and N-terminal LEDGF inter-
acts with stress-response elements (nA/TGGGGA/Tn),
thereby regulating transcription of small heat-shock proteins
(Hsps) such as aB-crystallin and Hsp27
1,12,13 and enhancing
cell survival.
1,14,15
Recently, aberrant expression of LEDGF was found to be
involved in development of various types of cancers including
subcutaneous angiogenesis and lymphangiogenesis of ovar-
ian carcinoma tumors.
16,17 More recently, elevated expres-
sion of LEDGF was reported in 61% of prostate tumors.
18
Moreover, stress-inducible LEDGF provides cell survival by
upregulating Hsp27.
1,19 Hsp27 belongs to the family of
‘survival proteins’ and its involvement has been found in a
number of cell death pathways induced by cellular and
environmental stresses.
20 We posit that LEDGF-mediated
overexpression ofHsp27 proteinmay alter the crucial balance
between cell proliferation and cell death, which in turn may
lead to cell transformation. Hsp27 can modulate cell prolifera-
tion by interacting with the Akt pathway, which has a pivotal
role in the survival of many types of cancer cells.
21–25 As
LEDGFisanenhancerofHsp27,andenhancedexpressionof
Hsp27 is known to be a causative factor in prostate cancer
(PC) progression and invasiveness,
26 we hypothesize that
LEDGF–induced tumorigenicity may be selectively asso-
ciated with upregulation of Hsp27-mediated antiapoptotic
signaling in PC cells.
27,28
During carcinogenesis, a large majority of signaling
molecules are affected, and their downstream effectors are
generally transcription factors. The smaller numbers of these
transcription factors may be an ideal target for treating/
postponing cancer formation.
29 Thus, we think that LEDGF
should be a potential and promising target for development of
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30 The RNA interference
technology has been shown to be a successful and effective
way of inhibiting the synthesis of speciﬁc protein.
31 In the
current study, we found that expression of LEDGF dramati-
cally elevated in PC cells, DU145, PC-3 and LNCaP.
Additionally, we showed that if LEDGF was overexpressed
in normal prostate cells, PWR-1E led to transformation, and
these cells showed characteristics of cancer cell, DU145.
Notably, DU145 cells aberrantly expressing LEDGF or over-
expressed with LEDGF displayed enhanced and aggressive
characteristic features of tumorigenicity (Figures 8 and 9). In
this work, we provide evidence that knocking down of LEDGF
in DU145 by LEDGF-targeted small interfering RNA (siRNA)
reduced tumorigenicity, and reduced tumorigenicity was
related to reduced expression of Hsp27 and attenuation of
Hsp27-mediated survival pathways(s). As a whole, our
ﬁndings not only offer new perspectives in the modulation of
cellulareventsbyLEDGFbutalsosuggestanoveltherapeutic
target for cancer treatment.
Results
Aberrant expression of LEDGF in human prostate
carcinoma cells DU145, PC-3 and LNCaP was associated
with increased expression of its downstream target
Hsp27. Using an androgen-independent PC cell line DU145
we studied whether increased expression of LEDGF was
associated with increased expression of Hsp27 and com-
pared with normal prostate epithelial cell line PWR-1E.
Analysis of LEDGF expression by real-time PCR and
western blot analyses showed that the DU145 cells harbored
signiﬁcantly elevated expression of LEDGF protein in
nucleus (Figure 1a, lane 2 versus 4) and mRNA (Figure 1b,
gray bar) compared with normal cells (PWR-1E). Interest-
ingly, mRNA expression of LEDGF in DU145 cells was
approximately seven-fold higher than in normal cells
(Figure 1b). Next, we tested whether levels of Hsp27 protein
and mRNA were also increased in DU145 cells, as LEDGF is
a regulator of Hsp27. Figure 1c (lane 2) and Figure 1d (gray
bar) demonstrate that indeed, the levels of Hsp27 were
elevated in DU145 cells.
Next, we examined whether the expression of LEDGF was
elevated in other androgen-dependent human PC cell lines,
PC-3 and LNCaP. As shown in the Figure 1e, these cell lines
also harbored elevated LEDGF protein (Figure 1e, upper
panel; lanes 2, 3 and 4). Observed increased levels of Hsp27
in these cell lines (Figure 1e, middle panel; lane 1 versus 2, 3
and 4) indicating a correlation between LEDGF expression
andHsp27.Furthermore,theexpressionlevelsofLEDGFand
Hsp27mRNAwerealsosigniﬁcantlyhigherinthePCcelllines
(Figure 1f) as evidenced by real-time PCR. In the current
study, we have chosen to perform experiments using normal
cells PWR-1E and DU145.
LEDGF overexpression enhanced the transactivation of
Hsp27 promoter and increased the migration and
invasiveness of DU145 cells. On the basis of our earlier
work,
1 we hypothesized that the increased expression of
LEDGF may be one factor in the increased Hsp27 expres-
sion in DU145 cells. To test this, we ﬁrst conﬁrmed
localization pattern and integrity of ectopically expressed
pEGFP-LEDGF in DU145. Figure 2A showed that the
ectopically expressed pEGFP-LEDGF protein localized in
nucleus. Next, we wished to examine DU145 containing
elevated expression of LEDGF, whether these cells over-
expressed with LEDGF display further increase in the
expression of Hsp27 mRNA. DU145 cells were overex-
pressed with different concentrations (250, 500ng, 1 and
2mg) of pEGFP-LEDGF. Real-time PCR analysis revealed
LEDGF concentration-dependent increased expression of
LEDGF mRNA (Figure 2B, black bars) and Hsp 27
(Figure 2B, gray bars). The increases in Hsp27 mRNA
appeared to be associated with the abundance of LEDGF,
further supports LEDGF as a regulator of Hsp27.
To examine whether LEDGF transactivated Hsp27 promo-
ter in DU145, cells were co-transfected with varying concen-
trations of pEGFP-LEDGF or pEGFP-vector and Hsp27-CAT
(co-transfection and promoter activity) promoter. CAT values
increased signiﬁcantly with increasing concentration of the
LEDGF constructs (Figure 2C), indicating that Hsp27 was
transactivated by LEDGF.
To determine whether LEDGF overexpression in these
cells was functionally involved in enhancing tumorigenicity,
cells overexpressing LEDGF were subjected to migration and
invasion assays. In the migration assay, conﬂuent and
quiescent monolayers of cells were wounded. Photographs
were taken 24h after wounding to observe changes in
migration (Figure 2D), and the distance of cell migration to
the wound area was measured (Figure 2D right panel). Cells
overexpressing LEDGF were found to have greater migration
potential (Figure 2D). Also, we observed aggressive invasive
behaviorincellsoverexpressingLEDGF(Figures8CandDb).
Data analysis revealed that cells ectopically expressed with
LEDGF showed B45% increase in invasive behavior in
comparison with vector-transfected cells.
Knockdown of LEDGF in DU145 effectively downre-
gulated its downstream target Hsp27. To examine the
direct involvement of LEDGF in tumorigenesis, DU145 cells
were transfected with siRNA speciﬁc to LEDGF (Si-LEDGF)
or scrambled siRNA vectors (Si-Control). Stably selected
transfectants were examined for LEDGF mRNA (Figure 3a)
and protein (Figure 3b) by real-time PCR and western
blot. The results indicated that cells stably transfected with
siRNA LEDGF had signiﬁcantly reduced expression of
LEDGF. Next, we tested whether these cells displayed
lower expression of Hsp27 by performing western analysis
using anti-Hsp27 antibody. Data revealed that reduced
expression of Hsp27 was associated with LEDGF expression
level (Figure 3c). To rule out the down regulation of Hsp27
expression is speciﬁc to LEDGF depletion, and not due to
nonspeciﬁc silencing effects of siRNA used against LEDGF,
we reprobed the membrane with speciﬁc antibodies for
other proteins such as Sp1, Prdx6 and b-actin (Figure 3c).
Densitometry of immunoblots disclosed no change in the
expression pattern of Sp1 or Prdx6 or b-actin, suggesting
that Si-LEDGF speciﬁcally depleted LEDGF. To examine
further whether Si-LEDGF reduced promoter activity of
Hsp27, we performed transactivation assay. We found that
Si-LEDGF cells displayed reduced Hsp27 promoter activity
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Cell Death and Diseasecompared with Si-Control cells (Figure 3d, open bar versus
gray bar).
Furthermore, it is known that activated STAT3 upregulates
Hsp27 and facilitate phosphorylation of Hsp27 at serine
residue 78 and aberrant STAT3 signaling induces cell
malignancies. We, therefore, next examined the level of
STAT3 expression in LEDGF-depleted cells. We could
observe a reduced level of total (Figure 3e, upper panel)
andphosphorylated(Figure3e,middlepanel)formsofSTAT3
protein.
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Figure1 LEDGF,atransregulatorofHsp27,andHsp27wereaberrantlyco-expressedinDU145cancercells.(a)WesternanalysisofLEDGFproteinisolatedfromnormal
prostate epithelial cells, PWR-1E (upper panel, lanes 1 and 2) and human prostate carcinoma cell line DU145 (upper panel, lanes 3 and 4). Nuclear or cytosolic extracts from
conﬂuentcellswereprepared.EqualamountsofproteinwereresolvedthroughSDS-PAGEandimmunoblottedusinganti-LEDGF.Lowerpanelshowsmembraneprobedwith
b-actin antibody as loading/internal control. Each band of blot was quantiﬁed using densitometer shown as histogram (right). Images are representatives from three
independent observations. (b) mRNAlevel expressionof LEDGFwas analyzedby real-time PCR. TotalRNA was isolatedfrom PWR-1E(black bar) or DU145(gray bar) cells
and reverse transcribed. cDNA was subjected to real-time PCR analysis with speciﬁc primers. Data represent the mean±S.D. from three independent experiments
(**Po0.001). (c and d) Expression levels of Hsp27 protein (c) and mRNA (d) in PWR-1E and DU145 cells. Data represent the mean±S.D. from three independent
experiments (**Po0.001). (e and f) Expression levels of LEDGF and Hsp27 protein (e) and mRNA (f) in different prostate adenocarcinoma cell lines as indicated compared
with normal prostate epithelium-derived cell line PWR-1E. Data represent the mean±S.D. from three independent experiments (**Po0.001). Each band of blot was
quantiﬁed using densitometer shown at the right of western blot images
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Cell Death and DiseaseKnockdown of LEDGF in DU145 cells suppressed
proliferation and survival. To determine whether
Si-LEDGF attenuates the tumorigenic character of DU145
cells, we did proliferation/cell viability of stably transfected
Si-LEDGF-DU145. On day 0 (baseline), Si-LEDGF cells or
Si-Control cells were seeded at equal density, and cell
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Cell Death and Diseaseproliferation and survival were measured by MTS (A) and
BrdU incorporation (B) assays. At 24, 48 and 72h, the
increase in proliferation of tumor cells was assessed. At each
time point, the mean fold increase in proliferation and survival
of Si-LEDGF cells was statistically less than that in
scrambled siRNA-transfected cells (Figures 4A and B).
Ournext step was determining whether LEDGF knockdown
cells would take a relatively longer time to attain monolayer
conﬂuency compared with normal PWR-1E or scrambled Si-
Control cells. Cells were cultured in 6-well plates, and chase
culture was carried out up to 96h and photomicrographed
(Figure 4C). Comparisons between PWR-1E or Si-Control
and Si-LEDGF at different time points demonstrated that
Si-LEDGF cells displayed decreased migration/proliferation
(Figures 4Ci, j, k and l) compared with PWR-1E (Figures 4Ca–d)
or Si-Control (Figures 4Ce–h).
Knockdown of LEDGF induced S-phase and G2-M arrest
through downregulation of cyclin B1 in DU145 cells. To
characterize the process of inhibition of proliferation of Si-
LEDGF-DU145 cells, we analyzed the cell cycle progression
by FACS analysis as described elsewhere.
32 As shown in
Figure 5a, transfection of scrambled or control siRNA did not
affect the cell cycle proﬁle, whereas Si-LEDGF-transfected
cells showed an obvious decrease in the percentage of cells
with 2N DNA (B36.21%) content (Figure 5a). Interestingly,
LEDGF knockdown caused an enrichment of cells in the
S-phase (51.31%) and G2 phase (B12.48%). However, a
corresponding decrease of cells in the G1 phase (B36.21%)
was observed compared with Si-control cells (B62.19%),
indicating that LEDGF-deﬁcient cells having an impaired cell
cycle (Figure 5a). As before mitotic centrosome activation at
the G2–M transition, cell cycle progression through G2 to
mitosis is accompanied by an accumulation of cyclin B1, it
was appropriate to examine whether LEDGF knockdown
cells contained reduced levels of cyclins. Data revealed a
signiﬁcant reduction in the expression of G2-regulatory
kinase cyclin B1 (Figure 5b, lane 2) in Si-LEDGF cells.
LEDGF-depleted DU145 cells displayed increased
expression of Bax and underwent apoptosis. As
expected, analysis with TdT-mediated dUTP-biotin nick end
labeling (TUNEL) staining revealed more apoptotic nuclei in
Si-LEDGF-DU145 cells, with approximately 37% of the cell
population showing characteristic apoptotic nuclei (Figures
6Aa, b and B). As shown in Figure 6C, LEDGF knockdown
cells revealed a signiﬁcant increase in the expression of Bax
protein (Figure 6Ca, lane 2). Next, we examined the
expression pattern of Bcl2, Bcl-XL and procaspase or
caspases 9. Data revealed a signiﬁcant reduction in
expression of survival molecules Bcl2 (Figure 6Cb, lane 2)
and Bcl-xL (Figure 6Cc, lane 2) and caspase 9 was activated;
two apparent bands of molecular weight B47kDa (procas-
pase 9) and B35kDa (cleaved caspase-9) could be
observed, and the level of cleaved band (active form) was
found to be increased in Si-LEDGF-deﬁcient cells
(Figure 6Cd, lane 2).
LEDGF depletion attenuated cell invasion and migration
and stabilized activation of ERK/Akt. To address the role
of LEDGF in PC invasion and metastasis, siRNA-LEDGF-
and scrambled Si-Control-DU145 cells were allowed to
invade through polycarbonate membrane inserts. As shown
in Figures 7A and B, LEDGF knockdown showed reduced
invasive characteristics for cells (25% cell invasion) com-
pared with Si-Control cells (80% cell invasion). To further
examine the involvement of LEDGF in invasive behavior, we
performed an in vitro wound-healing assay using LEDGF-
depleted DU145 cells. Conﬂuent and quiescent monolayers
of scrambled Si-Control or Si-LEDGF stable DU145 cells
were wounded. At 24h later, cell migration or the distance of
cell migration to the wound area was measured (Figure 7C,
compare Ca versus Cb; Cc versus Cd). The wound-healing
ability of LEDGF-depleted cells was much slower than that of
scrambled Si-Control (Figures 7C and D).
Next we tested whether Hsp27-depedent ERK/Akt pathway
is activated in DU145 cells, and whether that pathway could
be inhibited by knocking down LEDGF. Western analysis
revealed the deactivation of ERK1/2 and Akt proteins in
Si-LEDGF-transfected cells (Figure 7E, lane 2), suggesting
that LEDGF stimulation of cancer cell progression may be
associated with the ERK/Akt pathway.
LEDGF overexpression reversed the stabilized viability,
proliferation and invasive behavior of LEDGF-depleted
DU145 cells. To determine whether re-overexpression of
LEDGF would reverse the stabilization of the viability,
proliferation and invasiveness of Si-LEDGF cells, we over-
expressed the Si-Control and Si-LEDGF cells with pEGFP-
vector or pEGFP-LEDGF. Cell proliferation and viability were
assessed after 24, 48 and 72h as stated in Materials and
Methods. At all time points, the viability (Figure 8A) and
proliferation (Figure 8B) rate was signiﬁcantly increased in
Si-LEDGF cells overexpressed with LEDGF. Interestingly,
Invasive assay using scrambled Si-Control and Si-LEDGF
cells overexpressed with pEGFP-vector or pEGFP-LEDGF
(Figures 8C and Dd), revealed an increase in invasive
potential of cells re-overexpressed with LEDGF.
Figure 2 Transactivation assay showing LEDGF-dependent activation of Hsp27 in DU145 cells and enhanced cell migration. (A) Representative images showing
localization pattern of pEGFP-V (a) or pEGFP-LEDGF (b) in DU145 cells following transfection. Cells were transfected with pEGFP-vector or pEGFP-LEDGF. After 48h cells
were subjected to ﬂuorescence microscopy and photomicrographed. (B) LEDGF overexpression enhanced the transcription of Hsp27. Data showing the real-time PCR
analysis of Hsp27 and LEDGF mRNA in cells overexpressing EGFP-LEDGF plasmids as indicated (**Po0.001). (C) Upper panel, diagrammatic representation of Hsp27
promotercontainingLEDGFbindingelementslinkedtoCATreporterplasmid.Lowerpanel,CAT-ELISAperformedinDU145cellsafterco-transfectionwithemptyCATvector
(black bar) or pCAT-Hsp27 along with varying concentrations of pEGFP-LEDGF (gray bars). (D) DU145 cells overexpressing LEDGF displayed higher migration activity.
Wound-healing assay was performed in DU145 cells transfected either with pEGFP-vector or pEGFP-LEDGF. Images are representatives from three independent
experiments. Green shows migration of cells transfected with either pEGFP-vector (a, c, e and g) or pEGFP-LEDGF (b, d, f and h). Migration distance was calculated using
NIS-Elements BR 3.10 image analyzer software (Nikon, Elgin, IL, USA) and is shown as a histogram (right panel, black bar versus gray bar). Data represent the mean±S.D.
from three independent experiments (**Po0.001)
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Cell Death and DiseaseLEDGF knock down cells overexpressing Hsp27, reacti-
vated ERK1/2 and Akt phosphorylation, regained its
viability, proliferation and migratory behavior. To exam-
ine whether overexpression of Hsp27, the downstream target
of LEDGF, in LEDGF-depleted cells could reverse the
process displaying tumorigenic properties, we ectopically
expressed Hsp27 by transfecting pCMV-Hsp27 (1 and 2mg)
into Si-LEDGF (LEDGF-depleted) and Si-Control cells. First,
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Cell Death and DiseaseFigure3 LEDGFknockdownexperimentsandco-transfectionassayinDU145cellsshowingLEDGF-dependentexpressionandtranscriptionofHsp27.(a)TotalRNAwas
isolated from DU145 cells of stably expressing Si-LEDGF (gray bar) or scrambled siRNA (black bar) and subjected to real-time PCR analysis for LEDGF mRNA. Levels of
expression were normalized with the Cp values obtained from b-actin. Data represent the mean±S.D. from three independent experiments (**Po0.001). (b) Western
analysis performed with cell lysates isolated from the Si-LEDGF or Si-Control cells using anti-LEDGF antibody. Lower panel, membrane probed with b-actin antibody as
loading/internal control. Each band of blot was quantiﬁed using densitometer shown at right (black bar versus gray bar). (c) Representative western analysis experiments
illustrating the expression of Hsp27 (upper panel) in Si-LEDGF (lane 2) or Si-Control (lane 1) cells. Lower panel, membrane probed with b-actin antibody as loading/internal
control. Representative western analysis of Sp1 and Prdx6 proteins (middle panel) validating the speciﬁc knockdown of LEDGF and its speciﬁc effect on downregulation of
Hsp27. Each band of blot was quantiﬁed using densitometer shown at right (black bar versus gray bar). (d) Upper panel, diagrammatic representation of Hsp27 promoter
containingLEDGFresponsiveelementslinkedtoCATbasicvector.LowerpanelshowstheCAT-ELISAperformedinstablytransfectedSi-LEDGForscrambledsiRNADU145
cells following transfection with empty CAT vector (black and light gray bars) or pCAT-Hsp27 (open and gray bars). Data represent the mean±S.D. from three independent
experiments (**Po0.001). (e) LEDGF-depleted DU145 cells showed decreased total and phosphorylated forms of STAT3. Western analysis performed with the lysate
prepared from Si-Control and Si-LEDGF cells. As shown in the Figure (lane 2), the level of STAT3 was decreased in LEDGF-depleted cells
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Figure 4 LEDGF depletion decreased the survival and proliferation of DU145 cells. (A) Graph showing the viability of Si-Control- and Si-LEDGF-transfected cells compared with
PWR-1E normal prostate epithelial cells. Cells were harvested and processed for cell viability assay at different time points by MTS assay as depicted. (B) BrdU incorporation assay
performed to evaluate theproliferation inLEDGF-depleted cells. Cellswere labeled withBrdU for the last 2h of culture and BrdU incorporation into DNAwas measured bycolorimetric
assay followed by absorbance measurement at 450nm as described by the company’s protocol (Roche Diagnostics GmbH). Data represent the mean±S.D. from three independent
experiments (**Po0.001; *Po0.01). (C) Representative photomicrographs of cultured cells attaining monolayer conﬂuency (PWR-1E, a–d; Si-Control, e–h; Si-LEDGF, i–l). Images
were taken at different time intervals as described in (C) with the aid of phase contrast microscope equipped with camera (Nikon Eclipse Ti-U phase contrast, Elgin, IL, USA)
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Cell Death and Diseasewe conﬁrmed the LEDGF silencing (Figure 9Aa) and its
dose-responsive effect on Hsp27 expression (Figure 9Ab).
The same membrane was reprobed with ERK and Akt
antibodies speciﬁc to phosphorylated or non-phosphorylated
forms. Interestingly, we could observe reactivation of both
ERK1/2 (Figure 9Ac, right panel; lanes 2 and 3) and Akt
(Figure 9Ae, right panel; lanes 2 and 3) proteins, indicating
involvement of LEDGF in PC progression is through Hsp27-
ERK/Akt signaling.
Next, we became interested to know whether above-
observed events, reactivation of ERK1/2 and Akt may also
reverse its viability, proliferation and migration behaviors. We
found that indeed, the overexpression of Hsp27 in LEDGF-
depleted cells, signiﬁcantly reversed its viability (Figure 9B),
proliferation (Figure 9C) and migratory behavior (Figure 9Dh,
i, k and l). Conversely, Si-Control cells overexpressed with
Hsp27 further enhanced its proliferation (Figures 9A and B)
and migratory behavior (Figures 9Db, c, e and f).
Ectopic expression of LEDGF in normal prostate
epithelial cells, PWR-1E, transformed them into invasive
cells. To determine whether normal prostate cells over-
expressing LEDGF initiate tumorigenesis, we transfected
PWR-1E cells with 1mg of pEGFP-LEDGF (Figure 10A). The
ectopic expression of LEDGF enhanced the survival
(Figure 10B) and proliferation (Figure 10C) of these cells
as evidenced by viability (MTS) and BrdU assays. Further-
more, in a parallel experiment, these cells were also used for
invasion assay. Data showed an induction of invasiveness in
these cells (Figures 10D and Eb).
Discussion
Our present work showed that androgen-independent DU145
and androgen-dependent PC-3 and LNCaP PC cell lines
tested using expression analysis displayed aberrant expres-
sion of LEDGF and Hsp27. Importantly, the expression level
of Hsp27 was well correlated with abundance of LEDGF
protein. We also found that normal cells, PWR-1E when
overexpressed with LEDGF led to expression of tumorigenic
property, arguing that LEDGF overexpression causes initia-
tion of tumorigenesis (Figures 10D and E). Furthermore,
DU145 having aberrant expression of LEDGF when over-
expressed with LEDGF revealed more aggressive tumori-
genic properties (Figure 2). In the above scenario we
concluded that transcriptional protein LEDGF is a crucial
factor required for progression and initiation of tumorigenesis.
LEDGF achieved this by upregulating Hsp27, and thereby
stimulating the survival signaling Akt/ERK pathway(s). Effec-
tive knockdown of LEDGF in DU145 cells, abolished its
tumorogenic properties through downregulation of Hsp27 and
deactivation of ERK/Akt proteins. Interestingly, LEDGF-
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Figure 5 LEDGF depletion induced S-phase and G2–M cell cycle arrest and failure to accumulate cyclin B1. (a) Si-Control and Si-LEDGF stably transfected DU145 cells
were plated in 100mm dishes and cultured for 24h. Cells were harvested and hypotonically lysed in a PI solution to stain the DNA. Nuclei were analyzed for DNA content by
ﬂow cytometry. Percentage of cell population at G1, S and G2 phases are shown on the right (compare Si-Control and Si-LEDGF). (b) Western analysis to examine altered
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Cell Death and Diseasedepleted DU145 cells when overexpressed with LEDGF or
Hsp27, a reversal of tumorigenic properties occurred in these
cells through the reactivation of ERK1/2/Akt proteins
(Figure 9), supporting the hypothesis that LEDGF has its role
in cancer progression through the upregulation of Hsp27.
Hsp27 has been reported to interact with STAT3, a crucial
transcription factor implicated in the maintenance and
antiapoptotic status of cancerous cells.
33,34 We found that
LEDGF-depleted cells exhibited reduced level of STAT3 and
phosphorylated forms (Figure 3e).
Furthermore,LEDGFhasrecentlyattracted attentionowing
to its frequent aberrant expression in tumor cells, and to its
cytoprotective and chemoresistance properties.
30 Our data
showed that it is possible to markedly reduce the expression
of LEDGF in DU145 cancer cells and its tumorigenicity/
metastasis, by the use of Si-LEDGF (Figure 7E). Further-
more, the increased LEDGF expression in prostate tumors
and BPH compared with normal prostate tissue suggests that
this protein might be upregulated during prostate carcinogen-
esis or development of inﬂammatory conditions of the
prostate.
18,30 Its relatively high expression in prostate tumors
and their adjacent ‘normal’ tissue is likely induced by
inﬂammation and oxidative stress, key factors underlying
prostate carcinogenesis.
35 Inﬂammation and oxidative stress
are associated with development of BPH, which may explain
our observation that LEDGF is also strongly expressed in
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Figure6 LEDGFdepletionpromotesapoptosisinDU145cells.(A)DeterminationofapoptosisinscrambledSi-Control-orSi-LEDGF-transfectedcellsbyTUNELstaining.
Images were taken in FITC (a versus b) and DAPI (c versus d) ﬁlters by ﬂuorescent microscope equipped with camera (A) (Nikon Eclipse Ti-U ﬂuorescent microscope). The
number of apoptotic nuclei was counted manually. Three randomly selected ﬁelds were taken to quantify the apoptotic cells, and percentage was calculated and is shown as
histogram (B, black bar versus gray bar). Data represent the mean±S.D. from three independent experiments (**Po0.001). (C) Representative images of western analysis
for apoptotic signaling-related proteins (Bax, Bcl2, Bcl-xL, procaspase 9 and cleaved caspase 9). Lower panel shows b-actin band as internal control. Each band of blot was
quantiﬁed using densitometer shown on the right (compare gray bar versus black bar)
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Cell Death and Diseasehuman prostate carcinomas, and this enhanced expression in
cancer cells such as DU145 may be a major event in
progression of cancer (Figures 7B–D).
Moreover, Hsp27 is a stress-induced molecular chaperone
that is highly expressed in castrate-resistant PC and other
cancers, and is often associated with metastasis and poor
prognosis.
36 In the present study, we observed that LEDGF
was aberrantly expressed, and the transactivation of LEDGF
promoter was much higher in human prostate carcinoma
cells, DU145. Interestingly, the effective depletion of LEDGF
resultedinadecreasedlevelofHsp27andpromoteractivityin
these cells. However, the effective knockdown of LEDGF in
DU145 cells led to a signiﬁcant decrease in their proliferation
rate as evidenced by BrdU assay (Figure 3) and delayed
monolayer conﬂuency. Overexpression/re-overexpression of
LEDGF signiﬁcantly increased the proliferative property and
viability in these cells as examined by BrdU and MTS assays,
respectively, emphasizing the indispensable role of LEDGF in
controlling cell proliferation. Also, the knockdown of LEDGF
reversed the apoptotic signaling in cancer cells, as shown by
an increase in Bax and cleaved caspase 9 expression and
downregulation of procaspase 9, Bcl2 and Bcl-xL proteins
(Figure 6D). Initiation of mitosis is known to be regulated by
the activation of cdc2–cyclin B complex.
37 Although we could
not show that cyclin B1 is the direct target of LEDGF, we did
observe that silencing of LEDGF induced activation of the
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Figure 7 Knockdown of LEDGF attenuated the invasiveness and migration of DU145 cells and thereby deactivated ERK1/2/Akt signaling. (A) Cell invasion assay was
carried out to evaluate the invasive behavior of cells after LEDGF depletion. Invasion index in percentage was calculated (open bar versus gray bar). Data represent the
mean±S.D. from three independent experiments (**Po0.001). (B) The invaded cells on the membrane were stained with CyQunt GR dye and images were captured under
FITCﬁlterbyNikonEclipseTi-Uﬂuorescentmicroscopeequippedwithcamera.Imagesare representativesfromthreeindependentexperiments(a,Si-Control;b,Si-LEDGF).
(C) Images from wound-healing assay performed to assess the role of LEDGF in prostate carcinoma cell migration. Si-Control (a and c) and Si-LEDGF (b and d) cells were
seededin 60mmpetriplatesandassaywas performed. (D)Histogramshowingthemigrationdistance calculatedfromwound-healing assay(blackbar versusgray bar).Data
representthe mean±S.D.fromthreeindependentexperiments(**Po0.001).(E)Western analysisperformedto analyzethephosphorylationstatusof majorMAPKkinases,
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Cell Death and Diseaseapoptotic signaling and S-phase and G2-arrest of the cells
signiﬁcantly (Figure 5a). However, we can expect more
remarkable and noticeable results following synchronization
of cells. However, in present study, we followed the methods
of Long et al.,
32 to produce natural and bona-ﬁde outcomes.
We think that synchronization of cells is not feasible or
cumbersome to occur in body’s natural cellular microenviron-
ment. However, in a previously published study, LEDGF was
found to interact with the S-phase kinase (Cdc7:ASK) during
cellcycleprogression.Itiswellknownthatinhighereukaryotic
cells, cyclin B1 is excluded from the nucleus by its NES-
dependent transport mechanism during interphase, and that
NES-mediated export of proteins from the nucleus, including
cyclin B1, has a role in the DNA damage-induced G2
checkpoint. Our results in this study suggest that the failure
todetectcyclin B1inthe nuclearfraction ofsiRNA-transfected
cells may be due to its DNA damage-induced G2 checkpoint.
Hsp27 is also involved in the regulation of Akt, inhibiting Bax
activation to enhance cell survival. We found that silencing of
the LEDGF gene deactivated these two important signaling
molecules. However, in this work we could be able
to demonstrate the efﬁciency of Si-LEDGF in blocking
or reducing growth and proliferation of PC cells in vitro and
inhibiting progression of tumorigenic properties of PC
cells. Our results from cell viability (MTS assay) and
proliferation (BrdU assay) coupled with migration and
invasion assays suggest that LEDGF may have role
in cancer proliferation. Targeting LEDGF knockdown strategy
may be useful tool to suppress growth of PC cells.
Furthermore, BrdU incorporation and cell cycle assays
revealed that Si-LEDGF delivery to DU145 cells induces cell
arrest at G2 level or their progression, and that in turn leads to
apoptotic cell death.
In conclusion, we demonstrated, for the ﬁrst time, that the
underlying mechanism involved in LEDGF deﬁciency blocks
carcinogenesis by suppressing Hsp 27-ERK1/2 and Akt
pathways in human PC cells DU145. Certainly, more work is
needed for a full understanding of the role of LEDGF in PC.
However, we were able to show that LEDGF knockdown
should be an effective strategy in developing more effective
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Cell Death and Diseaseand curative anticancer therapeutics in combination with
known cancer drugs, potentially leading to new treatments for
metastatic PC.
Materials and Methods
Cell lines. Human prostate adenocarcinoma cell lines DU145, PC-3 and
LNCaP were used in the present study. Observations were compared with normal
prostate epithelium cell line PWR-1E wherever necessary. All the cell lines were
obtained from the American Tissue Culture Collection (Bethesda, MD, USA). The
DU145 cells were cultured at 371C in a 5% CO2 atmosphere in minimum essential
medium (MEM) (Gibco-BRL, Bethesda, MD, USA) supplemented with 10% heat-
inactivated fetal calf serum (FCS). The MEM also contained 1mM L-glutamine,
25mM Hepes, 100 unit/ml penicillin and 100 mg/ml streptomycin. The PWR-1E
cells were cultured in Keratinocyte serum-free medium supplemented with growth
factors (Gibco-BRL). PC-3 and LNCaP cells were maintained in RPMI medium
supplemented with 10% heat-inactivated FCS, 1mM L-glutamine, 25mM Hepes,
100unit/ml penicillin and 100mg/ml streptomycin.
Real-time PCR. Total RNA was extracted from cells using TriZol Reagent
(Invitrogen, Carlsbad, CA, USA), and was used for ﬁrst-strand DNA synthesis
using SuperScript II (Invitrogen). PCR was performed with the following primer
sequences: human LEDGF (Forward primer: 50-CAGCAACAGCATCTGTTAATC-
TAAA-30 and reverse primer: 50-GGGCTGTTTTACCATCATTTTGG-30); human Hsp27
(forward primer: 50-TCCCTGGATGTCAACCACTT-30 and reverse primer: 50-GATG-
TAGCCATGCTCGTCCT-30) and human b-actin (forward primer: 50-CCAACCGCGA-
GAAGATGA-30 and reverse primer: 50-CCAGAGGCGTACAGGGATAG-30). All PCR
experiments are performed in Light Cycler 480 with SYBR Green ﬂuorescence detection
(Roche Diagnostics GmbH, Indianapolis, IL, USA).
Western blot analysis. Whole-cell extracts or nuclear extracts were
prepared as described earlier.
38 Equal amounts of protein samples were resolved
onto an SDS-PAGE. Following immunoblotting with primary antibodies; LEDGF
monoclonal (BD Biosciences, San Jose, CA, USA; Cat. no. 611714), Hsp27
polyclonal (Santa Cruz Biotechnology, Santa Cruz, CA, USA; Cat. no. sc-1048),
cyclin B1 (Cell Signaling Technology, Danvers, MA, USA; Cat. no. 4135), Bax
(Santa Cruz Biotechnology; Cat. no. sc-7480), Bcl2 (Cell Signaling Technology;
Figure 9 LEDGF knockdown cells overexpressing Hsp27 reactivated ERK1/2 and Akt phosphorylation, regained its viability, proliferation and migratory behavior.
(A) Representative images of western blot analysis performed for indicated proteins with cell lysates obtained from Si-Control (left panel) and Si-LEDGF (right panel) cells
overexpressing Hsp27 of two different concentrations 1mg (lane 2) and 2mg (lane 3) of pCMV-Hsp27 or pCMV vector (lane 1)). Equal amount of plasmids were maintained
with empty vector DNA in all transfections. The same membrane was used for striping and reprobed with different antibodies as indicated. Lower panel, b-actin band as
internal control. (B and C) Histogram showing cell viability (B) and BrdU incorporation (C) of Si-Control and Si-LEDGF cells overexpressed with pCMV-Hsp27 compared with
pCMVvector-transfected cells. Datarepresent themean±S.D.from three independentexperiments(**Po0.001).(D) Si-Controland Si-LEDGFcells overexpressing Hsp27
displayed higher migration activity. Wound-healing assay was performed in Si-sontrol and Si-LEDGF cells transfected either with pCMV-Hsp27 or pCMV vector. Images are
representatives from three independent experiments. Upper panel, migration of Si-control cells transfected with either pCMV vector (a and d) or pCMV-Hsp27 (b, c, e and f).
Lower panel, migration of Si-LEDGF cells transfected with either pCMV vector (g and j) or pCMV-Hsp27 (h, i, k and l). Migration distance was calculated using NIS-Elements
BR 3.10 image analyzer software (Nikon) and is shown as a histogram (right panel, black bar versus gray bar). Data represent the mean±S.D. from three independent
experiments (**Po0.001)
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Figure 10 Overexpression of LEDGF enhanced viability, proliferation and evoked invasive behavior of PWR-1E cells. (A) Representative images showing cells
overexpressed with pEGFP-V or pEGFP-LEDGF in PWR-1E cells. (B) Histogram showing viability of PWR-1E cells overexpressed with pEGFP-LEDGF (yellow bars)
compared with pEGFP-vector-transfected cells (blue bars) at time points shown (blue bars versus yellow bars). (C) Histogram showing proliferation of PWR-1E cells
overexpressed with pEGFP-LEDGF (yellow bars) compared with pEGFP-vector-transfected cells (blue bars) at time points shown (blue bars versus yellow bars) using BrdU
assay. Data represent the mean±S.D. from three independent experiments (**Po0.001). (D) Histogram showing the percentage of invasion index of PWR-1E cells
overexpressing EGFP-LEDGF (gray bar). Data represent the mean±S.D. from three independent experiments (**Po0.001). (E) Photomicrographs of CyQuant GR-stained
membrane with invaded cells (a, pEGFP-V; b, pEGFP-LEDGF). Images are of representatives from three independent experiments
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Cell Death and DiseaseCat. no. 2876), Bcl-XL (Santa Cruz Biotechnology; Cat. no. sc-7195), caspase-9
(Cell Signaling Technology; Cat. no. 9508), pERK1/2 (Cell Signaling Technology;
Cat. no. 9106), ERK1/2 (Cell Signaling Technology; Cat. no. 9107), Akt (Cell
Signaling Technology; Cat. no. 9272) and pAkt (Cell Signaling Technology;
Cat. no. 4051), Prdx6 (Santa Cruz Biotechnology; Cat. no.
sc-271368), Sp1 (Santa Cruz Biotechnology; Cat. no.sc-17824), STAT3 (Santa
Cruz Biotechnology; Cat. no.sc-482), membrane was visualized following standard
protocol and recorded with FUJIFILM-LAS-4000 luminescent image analyzer
(FUJIFILM Medical system Inc., Stamford, CT, USA).
Construction of Hsp27-CAT and EGFP-LEDGF constructs.
Hsp27-CAT construct was engineered as described previously.
13 Brieﬂy, a
forward primer containing a SacI site (50-GCGTCGAGCTCTCGAATTCATTT
GCTT-30) and reverse primer with a XhoI site (50-GCTCTCGAGGTCTGCTCAGAA
AAGTGC-30) were used to generate the fragment, which was cloned between the
EcoRI sites of the TA vector (Invitrogen). The Hsp27-TA construct was digested
with SacI and XhoI and promoter fragments was ligated to pCAT-Basic vector
(Promega, Madison, WI, USA). A construct containing a green ﬂuorescent protein
(GFP) and LEDGF cDNA was generated with the ‘living color system’ (Clontech,
Palo Alto, CA, USA) using the plasmid vector pEGFP-C1 (Clontech) for LEDGF
protein overexpression studies. Expression construct, pCMV-Hsp27 and empty
vector, pCMV-V, were purchased from Addgene (Cambridge, MA, USA).
CAT assay. The CAT assay was performed using a CAT-ELISA kit (Roche
Diagnostics GmbH). Cells were transfected/co-transfected with reporter construct
(Hsp27-CAT) and/or EGFP-LEDGF/Si-LEDGF expression vectors. After 48h of
incubation, cells were harvested, and extracts were prepared and protein was
normalized. CAT-ELISA was performed to monitor CAT activity, following the
manufacturer’s protocol. Absorbance was measured at 405nm using a microtiter
plate ELISA reader. Transactivation activities were adjusted for transfection
efﬁciencies using GFP or SEAP values. The transfection experiments were carried
out either with Superfactamine Reagent (Invitrogen) or using Neon Transfection
system (Invitrogen).
siRNA assay. The LEDGF-speciﬁc siRNA expression plasmid was designed
according to the method described earlier.
39 The sequence was selected from
location 1340–1360 (50-AAAGACAGCATGAGGAAGCGA-30). The sense and
antisense oligonucleotides with the internal loop were synthesized by Invitrogen.
These were annealed and ligated into the BamHI and HindIII sites of pSilencer
4.1-CMV hygro (Ambion, Carlsbad, CA, USA). pSilencer 4.1-pCMVhygro
expressing a scrambled siRNA (Ambion) was used as a control. siRNA constructs
were transfected into DU145 cell with Superfactamine Reagent (Invitrogen). At
24h after transfection, stable transfected cells were selected using 400mg/ml of
hygromycin (Invitrogen) over a period of 9 days. Silencing was conﬁrmed by
LEDGF mRNA and protein expression.
BrdU incorporation and MTS assay. Cell proliferation assay was
performed with BrdU incorporation assay kit according to manufacturer’s protocol
(Roche Diagnostics GmbH). Brieﬂy, equal number of cells was seeded in 96-well
plates at a density of 5000 cells/well. Following incubation cells were labeled with
BrdU for 2h, the OD was measured at 450nm. MTS assay performed to measure
the viability of the cells at different time points. In brief, 5000 cells/well were
seeded into 96-well plates. Following incubation with MTS dye, absorbance was
measured at 490nm.
Flow cytometry for cell cycle and apoptosis. Scrambled Si-Control-
and Si-LEDGF-transfected cells were grown in T75 culture ﬂask. After 24h, cells
were harvested, ﬁxed with 5ml of ice-cold 70% ethanol (41C). Cell pellets were
collected by centrifugation and resuspended in 400ml of PBS, 50ml of propidium
iodide (PI) solution (0.6mM) and 50ml of RNaseA (1mg/ml). After 30min cells
were analyzed for DNA content using a FACS ﬂow cytometer. Fluorescence from
the PI–DNA complex was estimated on a minimum of 20000 cells per sample and
analyzed with CellQuest Pro software.
TUNEL assay. Si-LEDGF- and scrambled Si-Control-transfected cells were
seeded onto coverslips and incubated for 24h. TUNEL staining (in situ cell death
detection kit, Roche Diagnostics GmbH) and staining with 40,6-diamidino-2-
phenylindole dihydrochloride (DAPI) (Dojindo Laboratories, Kumamoto, Japan)
were performed. The percentage of TUNEL-positive cells per total number of cells
was counted from the number of DAPI-stained nuclei in six different ﬁelds of each
slide for each group using the image analyzing software.
Wound-healing assay. Si-LEDGF-transfected and Si-Control-transfected
cells or pEGFP-V or pEGFP-LEDGF-transfected cells were seeded into 60-mm
dishes at 1.5 10
6 cells. The conﬂuent cell monolayer was scraped with a sterile
pipette tip with a ﬁxed diameter. For each dish, three–ﬁve wounds were made, and
three sites of regular wounds were selected and marked. Wounded monolayers were
then washed three times with PBS to remove cell debris. Cells were permitted to
migrate into the area of clearing for 24h. Immediately after wounding and at the end
of the experiment (after 24h), wounds were photographed and semiquantitative
measurements of wounds were taken. A mean width was determined, and the
average width of wound closure was calculated as described previously.
Cell invasion assay. Invasion assay was performed with Cytoselect TM
96-well cell invasion assay (Cell Biolabs, INC., San Diego, CA, USA) according to
manufacturer’s instructions. Brieﬂy, around 2 10
6 cells per well of both Si-
Control and Si-LEDGF or pEGFP-V- or pEGFP-LEDGF-transfected cells were
resuspended in serum-free MEM medium, and were seeded into the extracellular
matrix layer, which had been previously rehydrated at room temperature for 1–2h.
MEM media of 150ml containing 10% fetal bovine serum was added to the lower
chamber as chemo attractant. Cells were incubated for 24h at 371Ci naC O 2
incubator (5% CO2). Invaded cells on the bottom of the insert membrane were
dissociated from the membrane by incubation with cell detachment buffer and
subsequently lysed and detected by CyQuant GR dye. The ﬂuorescence was
quantiﬁed with a ﬂuorescence plate reader using a 480/535-nm ﬁlter set. Percent
invasion index was calculated by normalizing the ﬂuorescence reading of invaded
cells with total cell ﬂuorescence reading. Invaded cells on the membrane were
photomicrographed under ﬂuorescent microscope from each set of experiments,
by ﬁxing the membrane in methanol and then stained with CyQuant GR dye.
Statistical analysis. All the statistical analyses were done in Graphpad
Prism software (La Jolla, CA, USA). Comparison between two groups were done
with student t-test. Multiple comparisons were done by ANOVA. A P-value of
o0.01 and o0.001 was deﬁned as indicating a statistically signiﬁcant difference.
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